Natco Pharma Ltd has launched Carboplatin Injection, a generic version of Paraplatin, in the US market through its US subsidiary Natco Pharma USA LLC, targeting a market with estimated annual sales of $27.8 million. The Hyderabad-based pharmaceutical company has launched the product in manufacturing collaboration with Chennai-based Teyro Labs Pvt Ltd. The launch is expected […]